WithdrawnEarly Phase 1

Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab

0Started 2011-03

Plain-language summary

Does treatment with bevacizumab (Avastin) in combination with prior or current radiotherapy lead to optic neuropathy?

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed w Glioblastoma grade IV, and scheduled to begin chemo radiotherapy with Avastin Exclusion Criteria: * No diagnosis of GBM, not scheduled to begin treatment with avastin in combination with radiotherapy.

What they're measuring

Measurement of Visual Evoked Potentials (optic nerve function and visual processing) and optic nerve function in 10 patients.

Timeframe: 1 year

Trial details

NCT IDNCT01331616

SponsorWest Penn Allegheny Health System

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-07

View on ClinicalTrials.gov More Glioblastoma trials